Embecta Corp (EMBC)
$6.25 -4.73% Close Oct 30, 2026 Live
Embecta stock today
Embecta closed at $6.25 on October 30, 2026, down 4.73% on the day. Over the past year it returned -52.7% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $371 million.
$5.00$10.00$15.00
NovJan 2026MarMayJulSep
| Period | EMBC | S&P 500 (SPY) |
|---|---|---|
| 1 month | +10.4% | -0.9% |
| 3 months | +71.1% | +2.1% |
| Year to date | -46.4% | +11.7% |
| 1 year | -52.7% | +12.4% |
| 3 years | -54.0% | +88.5% |
Key statistics
- Market value
- $371M
- P/E (trailing)
- 4.3
- Forward P/E
- 3.5
- Price / sales
- 0.4
- Dividend yield
- 5.12%
- 52-week range
- $2.90 to $14.64
- Next report
- Nov 25, 2026
About Embecta
Manufactures and sells diabetes management products, including injection devices and related supplies.
Sector: Health Care
More on Embecta
- Financials: revenue, earnings and segmentsRevenue -4% in the year to Sep 2025
- Valuation: P/E history and peersP/E 4.3, median 9.6 at its last 4 year ends
- Returns: what $1,000 became$1,000 three years ago is $460.03 today
No forecast, no recommendation. This page describes Embecta Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.